Anbio Biotechnology funding history / development milestones

IPO上市,

2021.11.18,上交所

Note: collected from public online reports, for reference only.

People who follow Anbio Biotechnology also follow

Anbio Biotechnology Competitors (Similar Companies)

“Research, development, and production of in vitro diagnostic reagents”
“Precision medicine driven by proteomics”
“Mainly engaged in the production and sales of antibiotics, traditional”
“To produce more affordable and effective medicines for the Chinese peo”
“Build a famous brand in the pharmaceutical packaging industry, create ”
“A group enterprise dedicated to drug research and development, product”
“制冷管路制造基地”
“A domestic first-class, internationally renowned biotechnology enterpr”
肉制品 农产品 农产品加工 生猪养殖
“Products for the diagnosis and treatment of allergic diseases”
“A Top 500 Chinese enterprise integrating seven major industries includ”
会议系统 视频监控 安防 视频会议
“Hyaluronic acid raw material supplier”
绿色建筑 房屋建筑工程 工程总承包/EPC 直营
“综合通信解决方案提供商”